Immunomic Therapeutics, Inc.
Biotechnology company · Rockville, Maryland, United States
Immunomic Therapeutics, Inc. is a biotechnology company headquartered in Rockville, Maryland, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $641,978 in total, most recently in 2015. It has reported private securities offerings to the US SEC, most recently $6.5 million sold in a notice filed in 2025.
Immunomic Therapeutics at a glance
What does Immunomic Therapeutics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $641,978 in total (2014 to 2015). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
13 Form D notices; the most recent reported $6.5 million sold (2025).
Frequently asked questions about Immunomic Therapeutics
Where is Immunomic Therapeutics headquartered?
Immunomic Therapeutics, Inc. is headquartered in Rockville, Maryland, United States.
What does Immunomic Therapeutics do?
Immunomic Therapeutics, Inc. is a biotechnology company.
Similar companies
- REGENXBIO Inc.Rockville, Maryland, United States
- OncoC4, Inc.Rockville, Maryland, United States
- Integrated Biotherapeutics LLCRockville, Maryland, United States
- Sanaria Inc.Rockville, Maryland, United States
- CASI Pharmaceuticals, Inc (DE)Rockville, Maryland, United States
- OncoImmune, Inc.Rockville, Maryland, United States
- Rise Therapeutics, LLCRockville, Maryland, United States
- KinaRx, Inc.Rockville, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences